Experienced in Neurosarcoidosis

Dr. Walter W. Chatham

Rheumatology
Unlv Medicine
1707 W Charleston Blvd, Suite 230, 
Las Vegas, NV 
Accepting New Patients
Experienced in Neurosarcoidosis
Unlv Medicine
1707 W Charleston Blvd, Suite 230, 
Las Vegas, NV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Walter Chatham is a Rheumatologist in Las Vegas, Nevada. Dr. Chatham and is rated as an Experienced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Sjogren Syndrome, and Granulomatosis with Polyangiitis. Dr. Chatham is currently accepting new patients.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in AL
Hospital Affiliations
University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Walgreens
  •  Health Care Services Corporation
  •  SelectHealth
  •  Anthem
  •  Silverscript
  •  Clear Spring Health
View 26 More Insurances +

Locations

UNLV MEDICINE
1707 W Charleston Blvd, Suite 230, Las Vegas, NV 89102

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drugs: Rituximab, Standard therapy (Including Immunosuppressants), Standard therapy (Excluding Immunosuppressants), Steroid Taper
Study Phase: Phase 3
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Active_not_recruiting
Publish Date: January 20, 2025
Intervention Type: Other, Biological
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of VIB1116 in Conventional Dendritic Cell (cDC) and Plasmacytoid Dendritic Cell (pDC)-Mediated Rheumatic Diseases
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of VIB1116 in Conventional Dendritic Cell (cDC) and Plasmacytoid Dendritic Cell (pDC)-Mediated Rheumatic Diseases
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Drug: TAK-079
Study Phase: Phase 1
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multi-center, Randomized, Double-blinded, Placebo-controlled, Multiple-ascending-dose Study of Brentuximab Vedotin in Adults With Active Systemic Lupus Erythematosus
A Multi-center, Randomized, Double-blinded, Placebo-controlled, Multiple-ascending-dose Study of Brentuximab Vedotin in Adults With Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: June 11, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

8 Total Publications

CAR-T-Cell Therapy for Systemic Lupus Erythematosus: A Comprehensive Overview.
CAR-T-Cell Therapy for Systemic Lupus Erythematosus: A Comprehensive Overview.
Journal: International journal of molecular sciences
Published: August 24, 2024
Similar Doctors
Experienced in Neurosarcoidosis
Dr. Marven D. Cabling
Rheumatology
Experienced in Neurosarcoidosis
Dr. Marven D. Cabling
Rheumatology

Healthnomic Partners LLC

8440 S Eastern Ave, Suite A, 
Las Vegas, NV 
 (8.9 mi)
702-476-2287
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Marven Cabling is a Rheumatologist in Las Vegas, Nevada. Dr. Cabling and is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Rheumatoid Arthritis (RA), Calcium Pyrophosphate Arthritis, Osteoporosis, and Postmenopausal Osteoporosis. Dr. Cabling is currently accepting new patients.

Experienced in Neurosarcoidosis
Dr. Sonya Mehta
Rheumatology
Experienced in Neurosarcoidosis
Dr. Sonya Mehta
Rheumatology

Intermountain Medical Holdings Nevada Inc

8930 W Sunset Rd, Suite 140, 
Las Vegas, NV 
 (9.1 mi)
702-968-3240
Languages Spoken:
English, Hindi, Spanish
See accepted insurances
Accepting New Patients

Sonya Mehta is a Rheumatologist in Las Vegas, Nevada. Dr. Mehta and is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis, Necrotizing Vasculitis, and Mixed Connective Tissue Disease. Dr. Mehta is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Find Dr. Chatham's expertise for a condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile